Login / Signup

The effects of bone morphogenetic protein 2 and thrombopoietin treatment on angiogenic properties of endothelial cells derived from the lung and bone marrow of young and aged, male and female mice.

Ushashi C DadwalFazal Ur Rehman BhattiOlatundun D AwosanyaRohit U NagarajAnthony J PeruginiSeungyup SunConner R ValuchCaio de Andrade StautStephen K MendenhallNikhil P TewariSarah L MostardoMurad K NazzalHanisha L BattinaDonghui ZhouDeepa KanagasabapathyRachel J BlosserPatrick L MulcroneJiliang LiIzath Nizeet Aguilar
Published in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2021)
With an aging world population, there is an increased risk of fracture and impaired healing. One contributing factor may be aging-associated decreases in vascular function; thus, enhancing angiogenesis could improve fracture healing. Both bone morphogenetic protein 2 (BMP-2) and thrombopoietin (TPO) have pro-angiogenic effects. The aim of this study was to investigate the effects of treatment with BMP-2 or TPO on the in vitro angiogenic and proliferative potential of endothelial cells (ECs) isolated from lungs (LECs) or bone marrow (BMECs) of young (3-4 months) and old (22-24 months), male and female, C57BL/6J mice. Cell proliferation, vessel-like structure formation, migration, and gene expression were used to evaluate angiogenic properties. In vitro characterization of ECs generally showed impaired vessel-like structure formation and proliferation in old ECs compared to young ECs, but improved migration characteristics in old BMECs. Differential sex-based angiogenic responses were observed, especially with respect to drug treatments and gene expression. Importantly, these studies suggest that NTN1, ROBO2, and SLIT3, along with angiogenic markers (CD31, FLT-1, ANGPT1, and ANGP2) differentially regulate EC proliferation and functional outcomes based on treatment, sex, and age. Furthermore, treatment of old ECs with TPO typically improved vessel-like structure parameters, but impaired migration. Thus, TPO may serve as an alternative treatment to BMP-2 for fracture healing in aging owing to improved angiogenesis and fracture healing, and the lack of side effects associated with BMP-2.
Keyphrases
  • endothelial cells
  • gene expression
  • bone marrow
  • mesenchymal stem cells
  • cell proliferation
  • emergency department
  • climate change
  • risk assessment
  • middle aged
  • wound healing
  • high fat diet induced